1. Meloxicam in rheumatoid arthritis;Ahmed;Expert Opin. Drug Metab. Toxicol.,2005
2. Non-michaelis-menten kinetics in cytochrome P450-catalyzed reactions;Atkins;Annu. Rev. Pharmacol. Toxicol.,2005
3. Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery;Ayati;Eur. J. Endocrinol.,2015
4. Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation;Barnette;Biochem. Pharmacol.,2019
5. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam;Barnette;Toxicology,2020